BehaveNet®
Clinical Capsule™

  
Join Our Mailing List

Email:

For Email Newsletters you can trust
Follow updates to BehaveNet with Twitter

drug: dantrolene

 
Clinical class treatment of Neuroleptic Malignant Syndrome; antispastic, muscle relaxant
Action blocks release of Ca from sarcoplasmic reticulum
Chemical class hydantoin derivative
CSA schedule none
DEA number none
Routes of administration oral, intravenous
Associated with (substance-related)  

 

 disorders: none
Availability prescription
U.S. Preparations:

Dantrium®, Dantrium®  IV (P & G Pharmaceuticals) FDA approved for treatment of : chronic spasticity, malignant hyperthermia

Dose: 25 mg. 50 mg. 100 mg.
Color:  opaque orange & tan opaque orange & tan opaque orange & tan
Shape: round  
Type: capsule capsule capsule
Imprint:      


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2009 BehaveNet®